United Therapeutics EBITDA 2010-2025 | UTHR

United Therapeutics EBITDA for the quarter ending March 31, 2025 was $0.403B, a 8.43% increase year-over-year.

  • United Therapeutics 2024 EBITDA was 1.45B, a 17.07% increase from 2023.
  • United Therapeutics 2023 EBITDA was 1.238B, a 20.09% increase from 2022.
  • United Therapeutics 2022 EBITDA was 1.031B, a 70.19% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

United Therapeutics EBITDA 2010-2025 | UTHR

  • United Therapeutics 2024 EBITDA was 1.45B, a 17.07% increase from 2023.
  • United Therapeutics 2023 EBITDA was 1.238B, a 20.09% increase from 2022.
  • United Therapeutics 2022 EBITDA was 1.031B, a 70.19% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.